IL140669A0 - Powdery preparation for mucosal administration containing polymeric medicine - Google Patents

Powdery preparation for mucosal administration containing polymeric medicine

Info

Publication number
IL140669A0
IL140669A0 IL14066999A IL14066999A IL140669A0 IL 140669 A0 IL140669 A0 IL 140669A0 IL 14066999 A IL14066999 A IL 14066999A IL 14066999 A IL14066999 A IL 14066999A IL 140669 A0 IL140669 A0 IL 140669A0
Authority
IL
Israel
Prior art keywords
medicine
containing polymeric
mucosal administration
administration containing
powdery preparation
Prior art date
Application number
IL14066999A
Other languages
English (en)
Original Assignee
Kirin Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26422571&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL140669(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Kirin Amgen Inc filed Critical Kirin Amgen Inc
Publication of IL140669A0 publication Critical patent/IL140669A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/02—Peptides of undefined number of amino acids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/162—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/193—Colony stimulating factors [CSF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/27—Growth hormone [GH], i.e. somatotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Otolaryngology (AREA)
  • Diabetes (AREA)
  • Virology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Toxicology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
IL14066999A 1998-07-08 1999-07-01 Powdery preparation for mucosal administration containing polymeric medicine IL140669A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP19272298 1998-07-08
JP8154999 1999-03-25
PCT/JP1999/003563 WO2000002574A1 (fr) 1998-07-08 1999-07-01 Preparation en poudre pour administration par les muqueuses

Publications (1)

Publication Number Publication Date
IL140669A0 true IL140669A0 (en) 2002-02-10

Family

ID=26422571

Family Applications (2)

Application Number Title Priority Date Filing Date
IL14066999A IL140669A0 (en) 1998-07-08 1999-07-01 Powdery preparation for mucosal administration containing polymeric medicine
IL140669A IL140669A (en) 1998-07-08 2001-01-01 A powder preparation for administration through the mucosa containing a polymeric drug

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL140669A IL140669A (en) 1998-07-08 2001-01-01 A powder preparation for administration through the mucosa containing a polymeric drug

Country Status (27)

Country Link
US (2) US20050271728A1 (ko)
EP (2) EP1093818B9 (ko)
JP (1) JP3422775B2 (ko)
KR (1) KR100606857B1 (ko)
CN (1) CN1180839C (ko)
AT (1) ATE320816T1 (ko)
AU (1) AU764331B2 (ko)
BG (1) BG65040B1 (ko)
BR (1) BR9911890A (ko)
CA (1) CA2332559C (ko)
CZ (1) CZ300931B6 (ko)
DE (1) DE69930509T2 (ko)
DK (1) DK1093818T3 (ko)
EA (1) EA003672B1 (ko)
ES (1) ES2260916T3 (ko)
HK (1) HK1039283B (ko)
HU (1) HUP0103396A3 (ko)
IL (2) IL140669A0 (ko)
MX (1) MXPA01000032A (ko)
NO (1) NO20010042L (ko)
NZ (1) NZ509710A (ko)
PL (1) PL193805B1 (ko)
PT (1) PT1093818E (ko)
RS (1) RS49890B (ko)
SK (1) SK262001A3 (ko)
TW (1) TWI225411B (ko)
WO (1) WO2000002574A1 (ko)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2403962C (en) * 2000-03-31 2009-12-15 Kirin Beer Kabushiki Kaisha Powdery preparation for transmucosal administration comprising a medicine of high molecular weight and exhibiting an improved storage stability
HUP0303700A3 (en) * 2000-07-17 2006-07-28 Astellas Pharma Inc Chuo Ku Pharmaceutical composition improved in peroral absorbability
CN100450547C (zh) * 2002-01-16 2009-01-14 安斯泰来制药有限公司 改善口服吸收用药物组合物
SE0302947D0 (sv) 2003-01-24 2003-11-07 Magle Ab A composition material for transmucosal delivery
EA012306B1 (ru) * 2003-01-24 2009-08-28 Магле Холдинг Аб Композиционный материал для доставки через слизистые оболочки
GB0315632D0 (en) * 2003-07-04 2003-08-13 West Pharm Serv Drug Res Ltd Pharmaceutical formulations
EP1824450B1 (en) * 2004-10-11 2012-11-14 Nasaleze Patents Limited Compositions for intranasal administration
US8202550B2 (en) 2004-10-11 2012-06-19 Nasaleze Ppm Limited Compositions for intranasal administration
JP5103748B2 (ja) * 2005-02-16 2012-12-19 東レ株式会社 医薬組成物
CU23317A1 (es) * 2005-07-22 2008-10-22 Ct De Investigacia N Y Desarro Formulaciones nasales de eporh con bajo contenido de ã cido siã lico para el tratamiento de enfermedades del sistema nervioso central
WO2008127833A2 (en) * 2007-03-19 2008-10-23 University Of Florida Research Foundation, Inc. Enhancing efficacy of vaccines administered via the respiratory tract
JP5171102B2 (ja) * 2007-05-02 2013-03-27 東亜薬品株式会社 経鼻吸収用睡眠導入剤
US10463608B2 (en) 2008-09-29 2019-11-05 The Corporation Of Mercer University Microneedle-based transdermal delivery system and method of making same
US10004790B2 (en) 2008-09-29 2018-06-26 The Corporation Of Mercer University Nanospheres encapsulating bioactive material and method for formulation of nanospheres
US11524058B2 (en) 2008-09-29 2022-12-13 The Corporation Of Mercer University Oral dissolving films containing microencapsulated vaccines and methods of making same
CA2738855A1 (en) 2008-09-29 2010-04-01 The Corporation Of Mercer University Nanospheres encapsulating bioactive material and method for formulation of nanospheres
JP5804453B2 (ja) * 2009-05-14 2015-11-04 国立大学法人 東京大学 結晶性ポリオール微粒子及びその調製方法
DK3679941T3 (da) 2009-06-18 2022-11-14 Serenity Pharmaceuticals Llc Sikker indgivelse af desmopressin
US9060938B2 (en) * 2011-05-10 2015-06-23 Bend Research, Inc. Pharmaceutical compositions of active agents and cationic dextran polymer derivatives
GB201109311D0 (en) * 2011-06-03 2011-07-20 Avimir Ip Ltd Method and computer program for providing authentication to control access to a computer system
KR101867428B1 (ko) * 2012-04-04 2018-07-19 백스폼 엘엘씨 경구 백신 투여용의 개선된 항원보강제 시스템
CN104208029B (zh) * 2013-05-30 2017-06-06 上海医药工业研究院 一种鼻用疫苗组合物粉体制剂及其制备方法
WO2017062463A1 (en) 2015-10-05 2017-04-13 The Corporation Of Mercer University Nanospheres encapsulating bioactive material and method for formulation of nanospheres
US11628208B2 (en) 2015-10-05 2023-04-18 The Corporation Of Mercer University System and method for microneedle delivery of microencapsulated vaccine and bioactive proteins
EP3459529A1 (en) * 2017-09-20 2019-03-27 Tillotts Pharma Ag Preparation of sustained release solid dosage forms comprising antibodies by spray drying
CN112601541A (zh) * 2018-06-22 2021-04-02 比欧拉利克斯有限公司 口服给药的生物聚合物制剂
BR112022023307A2 (pt) * 2020-05-18 2022-12-20 Orexo Ab Composição farmacêutica para entrega de fármacos
EP4236921A1 (en) 2021-11-25 2023-09-06 Orexo AB Pharmaceutical composition comprising adrenaline
EP4226912A1 (en) * 2022-02-09 2023-08-16 Catalya A polymer to increase the bioavailability of a pharmaceutical compound

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US807552A (en) * 1904-07-30 1905-12-19 John Guiry Dumping-scow.
JPS59163313A (ja) * 1983-03-09 1984-09-14 Teijin Ltd 経鼻投与用ペプチドホルモン類組成物
IE58110B1 (en) * 1984-10-30 1993-07-14 Elan Corp Plc Controlled release powder and process for its preparation
JP2577743B2 (ja) * 1986-07-18 1997-02-05 中外製薬株式会社 安定な顆粒球コロニ−刺激因子含有製剤
US4760093A (en) * 1986-10-21 1988-07-26 American Home Products Corporation (Del.) Spray dried acetaminophen
US4721020A (en) * 1986-10-27 1988-01-26 Stumpf Gary B Ski sharpening guide and method of employing same
GB8723846D0 (en) * 1987-10-10 1987-11-11 Danbiosyst Ltd Bioadhesive microsphere drug delivery system
GB8904370D0 (en) * 1989-02-25 1989-04-12 Cosmas Damian Ltd Liquid delivery compositions
GB8920381D0 (en) * 1989-09-08 1989-10-25 Greater Glasgow Health Board Treatment of insulin-resistant diabetes
JP2841714B2 (ja) * 1990-05-22 1998-12-24 大正製薬株式会社 持効性点鼻剤
JP3283288B2 (ja) * 1991-03-08 2002-05-20 電気化学工業株式会社 生理活性ペプチド製剤
AU676315B2 (en) * 1993-06-30 1997-03-06 Takeda Chemical Industries Ltd. Stabilized solid pharmaceutical preparation and method of producing the same
JPH07118170A (ja) * 1993-10-19 1995-05-09 Dot:Kk 経鼻吸収薬物用キャリヤ、生理活性ペプチド組成物およびその製造法
US5958458A (en) * 1994-06-15 1999-09-28 Dumex-Alpharma A/S Pharmaceutical multiple unit particulate formulation in the form of coated cores
US5783178A (en) * 1994-11-18 1998-07-21 Supratek Pharma. Inc. Polymer linked biological agents
JPH08198772A (ja) * 1994-11-25 1996-08-06 Kirin Brewery Co Ltd 顆粒球コロニー刺激因子含有粉末経鼻投与製剤
US5688520A (en) * 1995-03-29 1997-11-18 Minnesota Mining And Manufacturing Company Transmucosal delivery of melatonin for prevention of migraine
US5807552A (en) * 1995-08-04 1998-09-15 Board Of Regents, The University Of Texas System Compositions for conferring immunogenicity to a substance and uses thereof
US6391338B1 (en) * 1995-09-07 2002-05-21 Biovail Technologies Ltd. System for rendering substantially non-dissoluble bio-affecting agents bio-available
JP3197221B2 (ja) * 1996-02-27 2001-08-13 帝人株式会社 吸収性が改善された粉末状経鼻投与組成物
JP3197222B2 (ja) * 1996-02-28 2001-08-13 帝人株式会社 粉末状経鼻投与組成物
JP3770666B2 (ja) * 1996-09-20 2006-04-26 株式会社ティ・ティ・エス技術研究所 経粘膜吸収製剤用組成物
US5889051A (en) * 1997-07-15 1999-03-30 Development Center For Biotechnology Stabilization of prostaglandin drug
AU9182498A (en) * 1997-10-03 1999-04-27 Elan Corporation, Plc Taste masked formulations
US6669951B2 (en) * 1999-08-24 2003-12-30 Cellgate, Inc. Compositions and methods for enhancing drug delivery across and into epithelial tissues
US8075520B2 (en) * 2006-04-06 2011-12-13 Reznik Alan M Arthroscopic fluid control device and method for controlling fluid flow in arthroscopic procedures

Also Published As

Publication number Publication date
US20050271728A1 (en) 2005-12-08
DK1093818T3 (da) 2006-07-17
EA200100118A1 (ru) 2001-08-27
YU1101A (sh) 2003-08-29
RS49890B (sr) 2008-08-07
US20090028814A1 (en) 2009-01-29
AU4395899A (en) 2000-02-01
CA2332559A1 (en) 2000-01-20
EA003672B1 (ru) 2003-08-28
KR100606857B1 (ko) 2006-08-01
HUP0103396A3 (en) 2002-05-28
NO20010042L (no) 2001-03-05
CZ20016A3 (en) 2001-05-16
TWI225411B (en) 2004-12-21
ES2260916T3 (es) 2006-11-01
EP1637154A2 (en) 2006-03-22
PT1093818E (pt) 2006-07-31
CZ300931B6 (cs) 2009-09-16
BR9911890A (pt) 2001-03-27
EP1093818B9 (en) 2007-10-17
DE69930509D1 (de) 2006-05-11
HK1039283A1 (en) 2002-04-19
CN1315864A (zh) 2001-10-03
NO20010042D0 (no) 2001-01-04
IL140669A (en) 2007-06-03
BG65040B1 (bg) 2007-01-31
CN1180839C (zh) 2004-12-22
EP1093818A4 (en) 2004-03-31
MXPA01000032A (es) 2002-10-17
KR20010053302A (ko) 2001-06-25
AU764331B2 (en) 2003-08-14
EP1637154A3 (en) 2007-08-15
DE69930509T2 (de) 2006-11-30
SK262001A3 (en) 2001-09-11
HUP0103396A2 (hu) 2002-02-28
HK1039283B (zh) 2005-04-29
PL193805B1 (pl) 2007-03-30
PL345456A1 (en) 2001-12-17
CA2332559C (en) 2008-01-15
ATE320816T1 (de) 2006-04-15
EP1093818B1 (en) 2006-03-22
BG105169A (en) 2001-12-29
WO2000002574A1 (fr) 2000-01-20
NZ509710A (en) 2003-10-31
JP3422775B2 (ja) 2003-06-30
EP1093818A1 (en) 2001-04-25

Similar Documents

Publication Publication Date Title
IL140669A0 (en) Powdery preparation for mucosal administration containing polymeric medicine
US4474752A (en) Drug delivery system utilizing thermosetting gels
GR3003420T3 (en) Buccal drug dosage form
BG102438A (en) Medicamentous form
ATE250593T1 (de) Taxal derivate, deren herstellung und diese enthaltende pharmazeutische zusammenstellungen
AU7347987A (en) Tumor necrosis factor formulation
BG100933A (en) Polymer coated tablets comprising amoxycilin and clavulanate
DE69606028D1 (de) Taxal derivate, deren herstellung und diese enthaltende pharmazeutische zusammensetzung
AU2352288A (en) Biodegradable implant
RU95109153A (ru) Гидрогелевый препарат с длительным высвобождением лекарства
DE69604889T2 (de) Mit ortho-Adamantylgruppe substituierte diaromatische Verbindungen, diese enthaltende pharmazeutische und kosmetische Zusammensetzungen und Verwendungen
KR101066763B1 (ko) 온도 반응성 전달계
EP1123696A4 (en) COMPOSITIONS FOR ORAL CAVITY
IE870064L (en) Sustained release capsule
IL96995A0 (en) Pharmaceutical compositions containing pimobendan and their preparation
MY130098A (en) Local drug delivery film for periodontal treatment
IL107147A0 (en) Combined polymers or copolymers,their preparation and pharmaceutical compositions comprising them
DE515995T1 (de) N-(5-thioxo-l-propyl)-l-cystein und derivate, deren herstellung und diese verbindungen enthaltende pharmazeutische zusammensetzungen.
SE9403905D0 (sv) New formulations
DE69003466T2 (de) Substituierte Thienopyrimidin-Derivate, deren Herstellung, pharmazeutische Zusammensetzungen und medizinische Verwendung.
DE69403110T2 (de) Zyklische Angiopeptin Derivate, deren Herstellung und pharmazeutische Zusammensetzungen
EP0811385A3 (en) Conjugate of a factor specifically recognizing interleukin-2 receptor with ribonuclease
RU2002131189A (ru) Анкардин-retard-средство пролонгированного антикальциевого действия
Syemyannikov The Mechanism of Formation of Microheterogeneity in Polymeric Oligoetheracrylate
CA2179419A1 (en) Sulfated polyvinyl alcohol polymers to stabilize pharmaceutical drug compounds

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed